Quoin Pharmaceuticals, Ltd. (QNRX)
NASDAQ: QNRX · Real-Time Price · USD
7.50
+0.37 (5.19%)
Feb 10, 2026, 4:00 PM EST - Market closed
Quoin Pharmaceuticals Market Cap
Quoin Pharmaceuticals has a market cap or net worth of $6.29 million as of February 10, 2026. Its market cap has increased by 101.77% in one year.
Market Cap
6.29M
Enterprise Value
3.35M
1-Year Change
101.77%
Ranking
Category
Stock Price
$7.50
Market Cap Chart
Since October 29, 2021, Quoin Pharmaceuticals's market cap has decreased from $97.17M to $6.29M, a decrease of -93.52%. That is a compound annual growth rate of -47.18%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 10, 2026 | 6.29M | -48.02% |
| Dec 31, 2025 | 12.11M | 127.24% |
| Dec 31, 2024 | 5.33M | 10.02% |
| Dec 29, 2023 | 4.84M | -29.65% |
| Dec 30, 2022 | 6.88M | -54.69% |
| Dec 31, 2021 | 15.19M | -84.36% |
| Oct 29, 2021 | 97.17M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Aptorum Group | 6.58M |
| Calidi Biotherapeutics | 6.31M |
| BiomX | 6.26M |
| Purple Biotech | 5.98M |
| VivoSim Labs | 5.95M |
| Alaunos Therapeutics | 5.87M |
| MetaVia | 5.84M |
| Mustang Bio | 5.75M |